BioCentury | Jan 7, 2013
Emerging Company Profile

MinervaX: More with less in GBS

...vaccine program that targets the six known variants of the protective D3 domain of the pilus backbone protein 2a (BP-2a)...
BioCentury | Jun 2, 2011
Targets & Mechanisms

Getting at the crux of the antigen

...a vaccine candidate targeting the six known variants of the protective D3 domain of the pilus backbone protein 2a (BP-2a)...
Items per page:
1 - 2 of 2